Comorbidity assessment and radiotherapy in elderly cancer patients

F. Fiorica, A. Stefanelli, R. Fisichella, U. Tirelli, M. Berretta

Research output: Contribution to journalArticlepeer-review


More than 60% of all cancer patients in Europe and the USA are older than 65 years at the time of diagnosis. Despite this, elderly patients are generally under-represented in clinical trials. There is a lack of clinical trials to drive evidence-based decision making in the elderly cancer patients. In this review, we address the most important issue surrounding the treatment of older cancer patients: comorbidity assessment.

Original languageEnglish
Pages (from-to)1605-1606
Number of pages2
JournalEuropean Review for Medical and Pharmacological Sciences
Issue number11
Publication statusPublished - 2012


  • Elderly patients
  • Geriatric oncology
  • Radiochemotherapy
  • Radiotherapy

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)


Dive into the research topics of 'Comorbidity assessment and radiotherapy in elderly cancer patients'. Together they form a unique fingerprint.

Cite this